Variations: Important Changes in the New Application Form
Recommendation

20 October 2026
Copenhagen, Denmark
An ECA Course prior to the 29th APIC/CEFIC Global GMP & Regulatory API Conference
In May of this year, the EU Commission brought together in one document the two guidelines on the handling of variations procedures and categorisation of changes (see our GMP News from 3 July 2013). Now, the application form for variation to a marketing authorisation has been updated too. A respective notification was released on 19 July 2013 on the EMA's News page. Marketing authorisation holders must take into account many more changes in the new application form than before. The most important variations which must be notified or approved in the new application form are listed below:
- Excipients: new excipient, new manufacturer, submission of a new / or updated CEP or deletion of a CEP.
- API: change in the date of a GMP audit at the manufacturer, another site for batch testing, other storage location for master and working cell bank, other batch size of the API / intermediates, amending changes to an approved Change Management Protocol, submission of a new / or updated CEP or deletion of a CEP (also applies to starting materials, reagents and intermediates).
- Finished products: another site for batch testing, changes in the manufacturing process including other intermediates, changes due to updated Pharmacopoeial monographs, changes in an approved stability testing plan, amending changes to an approved Change Management Protocol.
The introduction of a pharmacovigilance system according to the new pharmacovigilance legislation leads to many more changes.
The new application form has to be used from 4 August 2013 on. The electronic version of the application form will be put online as of 29 July 2013 on EMA's eSubmission page where you can already find a Guideline entitled "Electronic Application Form Data Exchange Standard 3.0" which describes the structure of the electronic application form.
A comparative document presents the modifications between the older version from 2009 and the new one. This comparison is available for ECA members in the ECA members' area.
Related GMP News
12.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
12.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
07.10.2026EDQM Updates Guidance on CEP Sister File Applications
23.09.2026IRIS Portal: EMA expands digital Procedure Management
16.09.2026EMA updates Procedural Guidance for Application Preparation


